Blood Test May Detect Cancer Earlier in People with NF1
Researchers from NCI and Washington University School of Medicine have developed a blood test that, they believe, could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1.
Covid Vaccines Prevented Nearly 140,000 Deaths by May
An NIA-supported study estimated that Covid-19 vaccinations prevented nearly 140,000 deaths in the U.S. by May 2021.
Monoclonal Antibody Prevents Malaria in Small Trial
One dose of a new monoclonal antibody discovered and developed at NIH safely prevented malaria for up to 9 months in people exposed to the malaria parasite. The small clinical trial is the first to demonstrate that a monoclonal antibody can prevent malaria in people.
Pain Management Class Packs a Punch
A new study suggests a single 2-hour session of a pain management skills class could offer as much benefit as 8 sessions of cognitive behavioral therapy for patients experiencing chronic low-back pain. Supported by NCCIH and NIDA, the study explored whether a compressed intervention could lead to the same benefits as a longer course of CBT.
Intranasal Covid-19 Vaccine Effective in Animal Studies
A nasal spray of the Oxford/AstraZeneca Covid-19 vaccine protected hamsters and monkeys against serious disease and reduced the amount of virus in the nose. Less virus in the nasal passages could reduce the risk that vaccinated individuals spread the virus.
Discovery Paves Way for New Sight-Saving Therapy
NEI-funded research offers a new path for preventing glaucoma vision loss. A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma.
Youth-Onset Type 2 Diabetes Complications Arise by Young Adulthood
People with type 2 diabetes diagnosed during youth have a high risk of developing complications at early ages and have a greater chance of multiple complications within 15 years after diagnosis.
Beyond Words: Device Helps Paralyzed Man Communicate
Researchers developed a device to decode brain activity into words in real time, allowing a person with paralysis to communicate in complete sentences.
Higher-Dose Buprenorphine May Enhance Opioid Use Disorder Treatment Outcomes
High-dose buprenorphine therapy, provided under emergency department (ED) care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a NIDA study.